Synthesis, DNA binding, hemolytic, and anti-cancer assays of curcumin I-based ligands and their ruthenium(III) complexes

Medicinal Chemistry Research

Volumn 22, Issue 3, 2013, Pages 1386-1398

  Ali, Imran ^a   Saleem, Kishwar ^a   Wesselinova, Diana ^b   Haque, Ashanul ^a  

^a JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

^b BULGARIAN ACADEMY OF SCIENCES   (Bulgaria)

Author keywords

Anti cancer profile; Chromatographic and spectroscopic studies; Curcumin I; DNA bindings; Hemolytic assay; Ruthenium complexes

Indexed keywords

4 HYDROXY 3,5 DIMETHOXY BENZALDEHYDE; 4 HYDROXYBENZALDEHYDE; BENZALDEHYDE DERIVATIVE; CURCUMIN; CURCUMIN I; LIGAND; METAL ION; RUTHENIUM COMPLEX; SEMICARBAZIDE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING AFFINITY; BIOLOGICAL ACTIVITY; BREAST CANCER; COLON ADENOCARCINOMA; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; CYTOTOXICITY; CYTOTOXICITY TEST; DRUG DNA BINDING; DRUG SYNTHESIS; FEMALE; GEOMETRY; HEMOLYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; KNOEVENAGEL CONDENSATION; LIVER CELL CARCINOMA; NONHUMAN; PURIFICATION; THIN LAYER CHROMATOGRAPHY; UTERINE CERVIX CANCER;

EID: 84874114841     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-012-0133-8     Document Type: Article

References (39)

1. http://www.cancer.gov/clinicaltrials/search/view?cdrid= 648267&version=HealthProfessional&protocolsearchid=6994018. Accessed 13 Feb 2012
2. Adams BK, Cai J, Armstrong J, Herold M, Lu YJ, Sun A, Snyder JP, Liotta DC, Jones DP, Shoji M (2005) EF24, a novel synthetic curcumin analog, induces apoptosis in cancer cells via a redox-dependent mechanism. Anticancer Drugs 16:63-275
3. Aggarwal BB, Kumar A, Bharti AC (2003) Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 23:363-398
4. Ali I, Rahisuddin SK, Haque A, El-Azzouny A (2010) Natural products: human friendly anticancer medications. Egypt Pharma J 9:133-179
5. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB (2007) Bioavailability of curcumin: problems and promises. Mol Pharm 4:807-818
6. 3+: VCD and AFM evidence of DNA condensation. Biopolymers 61:243-260
7. Arjmand F, Jamsheera A (2011) DNA binding studies of new valine derived chiral complexes of tin (IV) and zirconium (IV). Spectrochim Acta A 78:45-51
8. Barton JK, Danishefsky AT, Goldberg JM (1984) Tris (phenanthroline) ruthenium (II): stereoselectivity in binding to DNA. J Am Chem Soc 106:2172-2176
9. Brabec V, Novakova O (2006) DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity. Drug Resist Updat 9:111-122
10. Chittilapilly PS, Yusuff KKM (2008) Synthesis, characterization and biological properties of ruthenium (III) schiff base complex derived from 3-hydroxyquionoxaline-2-carboxaldehyde and salicylaldehyde. Ind J Chem 47A:848-853
11. Christie MS, Kenneth LR, David BW (2007) Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles. Toxicol Sci 97:163-180
12. 4 isomers and prevention of brain involvement on P388 leukemia and on P388/DDP subline. Eur J Can 29A:1873-1879
13. Duvoix A, Blasius R, Delhalle S, Schnekenburger M, Morceau F, Henry E, Dicato M, Diederich M (2005) Chemopreventive and therapeutic effects of curcumin. Cancer Lett 223:181-190
14. Erkkila KE, Odom DT, Barton JK (1999) Recognition and reaction of metallointercalators with DNA. Chem Rev 99:2777-2795
15. Ferrari E, Lazzari S, Marverti G, Pignedoli F, Spagnolo F, Saladini M (2009) Synthesis, cytotoxic and combined cDDP activity of new stable curcumin derivatives. Bioorg Med Chem 17:3043-3052
16. Frasca D, Ciampa J, Emerson J, Umans RS, Clarke MJ (1996) Effects of hypoxia and transferrin on toxicity and DNA binding of ruthenium antitumor agents in HeLa cells. Metal Based Drugs 4:197-209
17. John VD, Kuttan G, Krishnankutty K (2002) Anti-tumor studies of metal chelates of synthetic curcuminoids. J Exp Clin Cancer Res 21:219-224
18. Kelloff GJ, Crowell JA, Hawk ET, Steele VE, Lubet RA, Boone CW, Covey JM, Doody LA, Omenn GS, Greenwald P, Hong WK, Parkinso DR, Bagheri D, Baxter GT, Blunden M, Doeltz MK, Eisenhauer KM, Johnson K, Knapp GG, Longfellow DG, Malone WF, Nayfield SG, Seifried HE, Swall LM, Sigman CC (1996) Clinical development plans for cancer chemopreventive agents. J Cell Biochem 26:72-315
19. 2 (phen)/nucleotides aqueous and solid-state coordination chemistry and its DNA binding studies. J Inorg Biochem 64:181-195
20. Lina L, Lee KH (2006) Structure-activity relationships of curcumin and its analogs with different biological activities. Stud Nat Prod Chem 33:785-812
21. Liu J, Zhang H, Chen C, Deng H, Lu T, Ji L (2003) Interaction of macrocyclic copper (II) complexes with calf thymus DNA: effects of the side chains of the ligands on the DNA-binding behaviors. Dalton Trans 1:114-119
22. Lo Tempio MM, Veena MS, Steele HL, Ramamurthy B, Ramalingam TS, Cohen AN, Chakrabarti R, Srivatsan ES, Wang MB (2005) Curcumin suppresses growth of head and neck squamous cell carcinoma. Clin Can Res 11:6994-7002
23. Manoharan S (1996) Inhibition of 4-nitroquinoline-l-oxide-induced oral carcinogenesis by plant product. J Clin Biochem Nutr 21:141-149
24. Mestroni G, Alessio E, Sava G, Pacor S, Coluccia M, Boccarelli A (1993) Water soluble ruthenium(III)-dimethyl sulfoxide complexes: chemical behavior and pharmaceutical properties. Met Based Drugs 1:41-63
25. 2-induced DNA damage and alter its site specificity. FEBS Lett 495:187-190
26. Modukuru NK, Snow KJ, Perrin BS Jr, Thota J, Kumar CV (2005) Contributions of a long side chain to the binding affinity of an anthracene derivative to DNA. J Phys Chem B 109:11810-11818
27. Ohtsu H, Xiao Z, Ishida J, Nagai M, Wang HK, Itokawa H, Su CY, Shih C, Chiang T, Chang E, Lee Y, Tsai MY, Chang C, Lee KH (2002) Curcumin analogues as novel androgen receptor antagonists with potential as anti-prostate cancer agents. J Med Chem 45:5037-5042
28. Padhye S, Yang H, Jamadar A, Cui QC, Chavan D, Dominiak K, McKinney J, Banerjee S, Dou QP, Sarkar FH (2009) New difluoro Knoevenagel condensates of curcumin, their Schiff bases and copper complexes as proteasome inhibitors and apoptosis inducers in cancer cells. Pharma Res 26:1874-1880
29. Parka HC, Hahma ER, Parkb S, Kima HK, Yang CH (2005) The inhibitory mechanism of curcumin and its derivative against β-catenin/Tcf signaling. FEBS Lett 579:2965-2971
30. Priya NP, Arunachalam S, Manimaran A, Muthupriya D, Jayabalakrishna C (2009) Mononuclear Ru(III) Schiff base complexes: synthesis, spectral, redox, catalytic and biological activity studies. Spectrochim Acta A 72:670-676
31. Qiu X, Liu Z, Shao WY, Liu X, Jing DP, Yu YJ, An LK, Huang SL, Bu XZ, Huang ZS, Gu LQ (2008) Synthesis and evaluation of curcumin analogues as potential thioredoxin reductase inhibitors. Bioorg Med Chem 16:8035-8041
32. Situ H, Bobek LA (2000) In vitro assessment of antifungal therapeutic potential of salivary histatin-5, two variants of histatin-5, and salivary mucin (MUC7) domain1. Antimicrob Agents Chemother 44:1485-1493
33. Stephanos JJ, Farina SA, Addison AW (1996) Iron ligand recognition by monomeric hemoglobin's. Biochim Biophy Acta 1295:209-221
34. Wang Y, Yan ZY (2005) Synthesis, characterization and DNA-binding properties of three 3d transition metal complexes of the Schiff base derived from diethenetriamine with PMBP. Trans Metal Chem 30:902-906
35. Wu JZ, Yuana L, Wu JF (2005) Synthesis and DNA binding of μ-[2,9-bis(2-imidazo[4,5-f] [1,10]phenanthroline)-1,10-phenanthroline]bis[1, 10-phenanthrolinecopper(II)]. J Inorg Biochem 99:2211-2216
36. Xu ZD, Liu H, Xiao SL, Yang M, Bu XH (2002) Synthesis, crystal structure, antitumor activity and DNA-binding study on the Mn(II) complex of 2H-5-hydroxy-1,2,5-oxadiazo[3,4-f]1,10-phenanthroline. J Inorg Biochem 90:79-84
37. Cell Titer 96 Non-Radioactive Cell Proliferation Assay. Technical Bulletin #TB112, Promega Corporation USA. Revised 12/99
38. Zeller WJ, Fruhauf S, Chen G, Keppler BK, Frei E, Kaufmann M (1991) Chemoresistance in rat ovarian tumours. Eur J Can 27:62-67
39. Zhang Q, Fu Y, Wang HW, Gong T, Qin Y, Zhang ZR (2008) Synthesis and cytotoxic activity of novel curcumin analogues. Chin Chem Lett 19:281-285